It has been theorized that BPC 157 therapy could likely represent a bypassing key, by rapidly activating bypassing pathways and abrogating the complex syndrome induced by simultaneous occlusion of essential arterial and venous tributaries
Results from RxPros may vary
So it's not something that should be used haphazardly
Symptoms include: extreme tiredness, lack of energy, pins and needles, muscle weakness, depression and problems with memory, understanding and judgement
Energy utilization markers tracked in structured cellular efficiency studies
To get it approved, you would need to: Buy the patent (its for sale) Figure out a specific disease indication to apply for BPC-157 approval Hire a research team to run phase 1, 2, 3 trials The financial incentives make it so that BPC-157 will likely never go through the full FDA approval process, which is a shame given how promising this compound is